These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Risk assessment, symptoms, and signs as predictors of vulvovaginal and cervical infections in an urban US STD clinic: implications for use of STD algorithms. Ryan CA; Courtois BN; Hawes SE; Stevens CE; Eschenbach DA; Holmes KK Sex Transm Infect; 1998 Jun; 74 Suppl 1():S59-76. PubMed ID: 10023355 [TBL] [Abstract][Full Text] [Related]
7. Characterization of women with a history of recurrent vulvovaginal candidosis. Novikova N; Mårdh PA Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1047-52. PubMed ID: 12421173 [TBL] [Abstract][Full Text] [Related]
8. Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment. Ventolini G; Baggish MS Maturitas; 2005 Jul; 51(3):294-8. PubMed ID: 15978973 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Ahmad A; Khan AU Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):68-71. PubMed ID: 19261369 [TBL] [Abstract][Full Text] [Related]
10. Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture. Linhares LM; Witkin SS; Miranda SD; Fonseca AM; Pinotti JA; Ledger WJ Infect Dis Obstet Gynecol; 2001; 9(4):221-5. PubMed ID: 11916179 [TBL] [Abstract][Full Text] [Related]
12. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. Mendling W; Brasch J; ; ; ; Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657 [TBL] [Abstract][Full Text] [Related]
13. [Vulvovaginal mycoses]. Mendling W Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):175-9. PubMed ID: 9606884 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of a clinimetric scale for diagnosing vulvovaginal candidosis]. Reyna Figueroa J; Morales Rangel V; Ortiz Ibarra FJ; Casanova Román G; Beltrán Zúñiga M Ginecol Obstet Mex; 2004 May; 72():219-26. PubMed ID: 15460433 [TBL] [Abstract][Full Text] [Related]
15. Performance of a rapid yeast test in detecting Candida spp. in the vagina. Dan M; Leshem Y; Yeshaya A Diagn Microbiol Infect Dis; 2010 May; 67(1):52-5. PubMed ID: 20226617 [TBL] [Abstract][Full Text] [Related]
16. A retrospective study of relevant diagnostic procedures in vulvodynia. Petersen CD; Kristensen E; Lundvall L; Giraldi A J Reprod Med; 2009 May; 54(5):281-7. PubMed ID: 19517691 [TBL] [Abstract][Full Text] [Related]
17. [Usefulness of fresh wet mount examination in the diagnosis of vaginal candidiasis]. Casanova Roman G; Narcio Reyes LE; Ortiz Ibarra FJ; Beltrán Zuñiga M; Castelazo Morales E Ginecol Obstet Mex; 1997 Mar; 65():87-91. PubMed ID: 9190357 [TBL] [Abstract][Full Text] [Related]
18. [Retrospective study of mycotic and other colpitis pathogens]. Pupp C; Ginter G Wien Med Wochenschr; 1989 Aug; 139(15-16):366-8. PubMed ID: 2688322 [TBL] [Abstract][Full Text] [Related]
19. Vulvovaginal candidiasis: Etiology, symptomatology and risk factors. Mtibaa L; Fakhfakh N; Kallel A; Belhadj S; Belhaj Salah N; Bada N; Kallel K J Mycol Med; 2017 Jun; 27(2):153-158. PubMed ID: 28314677 [TBL] [Abstract][Full Text] [Related]
20. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Seidman LS; Skokos CK Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]